Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps

Nutrition and Cancer

Volumn 63, Issue 3, 2011, Pages 319-326

  Adams, Scott V ^a,b   Newcomb, Polly A ^a,b   Burnett Hartman, Andrea N ^a,b   White, Emily ^a,b   Mandelson, Margaret T ^b,c   Potter, John D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL POLYPOSIS; HEALTH CARE PLANNING; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL ACTIVITY; QUESTIONNAIRE; RISK FACTOR; VITAMIN SUPPLEMENTATION;

ADENOMA; AGED; CASE-CONTROL STUDIES; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; VITAMIN D;

EID: 79957539517     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.535960     Document Type: Article

References (50)

1. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87, 159-70, 1996. (Pubitemid 26358996)
2. Jass JR: Hyperplastic-like polyps as precursors of microsatellite- unstable colorectal cancer. Am J Clin Pathol 119, 773-775, 2003.
3. O'Brien MJ: Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 36, 947-968, 2007.
4. Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, 113-130, 2007.
5. East JE, Saunders BP, and Jass JR: Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 37, 25-46, 2008. (Pubitemid 351289032)
6. Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, et al.: Vitamin D and cancer. J Steroid Biochem Mol Biol 102, 156-162, 2006. (Pubitemid 44781185)
7. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al.: Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29, 726-776, 2008.
8. DeLuca HF: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80, 1689S-1696S, 2004.
9. Holick MF: Sunlight and vitamin d for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 1678S-1688S, 2004.
10. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, et al.: 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 357, 1673-1674, 2001. (Pubitemid 32568244)
11. Hollis BW: Assessment of vitamin d status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 15, 489-494, 2008.
12. Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, et al.: Circulating vitamin d metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 13, 546-552, 2004. (Pubitemid 38737889)
13. Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, et al.: Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10, 1267-1274, 2001. (Pubitemid 34027758)
14. Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, et al.: Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 39, 35-41, 2001. (Pubitemid 32880946)
15. Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, et al.: Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 9, 1059-1065, 2000.
16. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, et al.: Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95, 1765-1771, 2003. (Pubitemid 38008899)
17. Wei MY, Garland CF, Gorham ED, Mohr SB, and Giovannucci E: Vitamin Dand prevention of colorectal adenoma: ameta-analysis. Cancer Epidemiol Biomarkers Prev 17, 2958-2969, 2008.
18. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, et al.: Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32, 210-216, 2007. (Pubitemid 46223622)
19. Yin L, Grandi N, Raum E, Haug U, Arndt V, et al.: Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30, 113-125, 2009.
20. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, et al.: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354, 684-696, 2006. (Pubitemid 43247139)
21. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586-1591, 2007. (Pubitemid 46890428)
22. Holick MF: Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 354, 2287-2288; author reply 2287-2288, 2006.
23. Giovannucci E: Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med, 354, 2287-2288; author reply 2287-2288, 2006.
24. Ding EL, Mehta S, Fawzi WW, and Giovannucci EL: Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of women's health initiative randomized trial. Int J Cancer 122, 1690-1694, 2008. (Pubitemid 351413414)
25. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, et al.: Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 11, 1012-1018, 2002.
26. Lieberman DA, Prindiville S, Weiss DG, and Willett W: Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290, 2959-2967, 2003. (Pubitemid 37505528)
27. Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, et al.: Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 16, 2697-2703, 2007. (Pubitemid 351196326)
28. Maunsell Z, Wright DJ, and Rainbow SJ: Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51, 1683-1690, 2005. (Pubitemid 41233104)
29. Huncharek M, Muscat J, and Kupelnick B: Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer 61, 47-69, 2009.
30. Vogeser M: Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol 121, 565-573, 2010.
31. Yetley EA: Assessing the vitamin D status of the U.S. population. Am J Clin Nutr 88, 558S-564S, 2008.
32. Holick MF: Vitamin D deficiency. N Engl J Med 357, 266-281, 2007.
33. Ko JA, Lee BH, Lee JS, and Park HJ: Effect of UV-B exposure on the concentration of vitamin D2 in sliced shiitake mushroom (lentinus edodes) and white button mushroom (agaricus bisporus). J Agric Food Chem 56, 3671-3674, 2008. (Pubitemid 351860168)
34. Fedirko V, Bostick RM, Goodman M, Flanders WD, and Gross MD: Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. American Journal of Epidemiology 172, 489-500, 2010.
35. Oh K, Willett WC, Wu K, Fuchs CS, and Giovannucci EL: Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 165, 1178-1186, 2007. (Pubitemid 47233720)
36. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, et al.: Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171, 903-908, 2010.
37. Hofmann JN, Yu K, Horst RL, Hayes RB, and Purdue MP: Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19, 927-931, 2010.
38. Ginde AA, Liu MC, and Camargo CA: Demographic differences and trends of vitamin D insufficiency in the U.S. population, 1988-2004. Archives of Internal Medicine 169, 626-632, 2009.
39. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, and Van Leeuwen JP: Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143-156, 2004. (Pubitemid 39094759)
40. Chia VM and Newcomb PA: Calcium and colorectal cancer: some questions remain. Nutr Rev 62, 115-120, 2004.
41. Wallace K, Baron JA, Cole BF, Sandler RS, Karagas MR, et al.: Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 96, 921-925, 2004. (Pubitemid 38868138)
42. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, et al.: Calcium supplements for the prevention of colorectal adenomas. calcium polyp prevention study group. N Engl J Med 340, 101-107, 1999. (Pubitemid 29054844)
43. Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, et al.: Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 167, 1050-1058, 2008. (Pubitemid 351601236)
44. Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, et al.: The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 18, 2310-2317, 2009.
45. Potter JD, Bigler J, Fosdick L, Bostick RM, Kampman E, et al.: Colorectal adenomatous and hyperplastic polyps: smoking and n-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev 8, 69-75, 1999. (Pubitemid 29090872)
46. Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, et al.: Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 15, 897-901, 2006. (Pubitemid 43823515)
47. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, et al.: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154, 369-387, 2001. (Pubitemid 34286147)
48. Deeb KK, Trump DL, and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7, 684-700, 2007. (Pubitemid 47327412)
49. Byers S and Shah S: Vitamin D and the regulation of wnt/beta-catenin signaling and innate immunity in colorectal cancer. Nutr Rev 65, S118-S120, 2007.
50. Egan JB, Thompson PA, Vitanov MV, Bartik L, Jacobs ET, et al.: Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor foki polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol Carcinog 49, 337-352, 2010.